Research statistics

Delta Sleep-Inducing Peptide (DSIP) research: publications and trials

What has been published on Delta Sleep-Inducing Peptide (DSIP): PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Delta Sleep-Inducing Peptide (DSIP) works or is safe. For what it is and what the studies found, see the Delta Sleep-Inducing Peptide (DSIP) profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

499

Since 1977

Publications in 2026 so far

0

Through November 15, 2026

Human clinical research

11.1%

53 of 478 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

6

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

80.1%

351 animal · 26 in vitro · 6 computational

Records that only mention it

42

Not counted above

Status in the library: Research only. Groups: Cognitive and neurological peptides. 21 publications are not yet classified by study type.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.
  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

Delta Sleep-Inducing Peptide (DSIP) publications by year and evidence

1977, Preclinical (animal, in vitro, computational): 5 of 61977, Other and not yet classified: 1 of 61978, Preclinical (animal, in vitro, computational): 3 of 41978, Other and not yet classified: 1 of 41979, Preclinical (animal, in vitro, computational): 2 of 21980, Preclinical (animal, in vitro, computational): 8 of 81981, Human clinical research: 3 of 111981, Preclinical (animal, in vitro, computational): 6 of 111981, Other and not yet classified: 2 of 111982, Preclinical (animal, in vitro, computational): 11 of 121982, Other and not yet classified: 1 of 121983, Human clinical research: 2 of 201983, Preclinical (animal, in vitro, computational): 15 of 201983, Reviews and meta-analyses: 1 of 201983, Other and not yet classified: 2 of 201984, Human clinical research: 6 of 411984, Preclinical (animal, in vitro, computational): 23 of 411984, Reviews and meta-analyses: 6 of 411984, Other and not yet classified: 6 of 411985, Human clinical research: 1 of 181985, Preclinical (animal, in vitro, computational): 13 of 181985, Reviews and meta-analyses: 3 of 181985, Other and not yet classified: 1 of 181986, Human clinical research: 1 of 281986, Preclinical (animal, in vitro, computational): 24 of 281986, Reviews and meta-analyses: 2 of 281986, Other and not yet classified: 1 of 281987, Human clinical research: 4 of 231987, Preclinical (animal, in vitro, computational): 17 of 231987, Reviews and meta-analyses: 1 of 231987, Other and not yet classified: 1 of 231988, Human clinical research: 1 of 211988, Preclinical (animal, in vitro, computational): 16 of 211988, Reviews and meta-analyses: 3 of 211988, Other and not yet classified: 1 of 211989, Human clinical research: 2 of 261989, Preclinical (animal, in vitro, computational): 21 of 261989, Reviews and meta-analyses: 1 of 261989, Other and not yet classified: 2 of 261990, Human clinical research: 1 of 261990, Preclinical (animal, in vitro, computational): 19 of 261990, Reviews and meta-analyses: 4 of 261990, Other and not yet classified: 2 of 261991, Human clinical research: 3 of 241991, Preclinical (animal, in vitro, computational): 21 of 241992, Human clinical research: 6 of 281992, Preclinical (animal, in vitro, computational): 20 of 281992, Reviews and meta-analyses: 2 of 281993, Human clinical research: 2 of 171993, Preclinical (animal, in vitro, computational): 12 of 171993, Reviews and meta-analyses: 3 of 171994, Human clinical research: 4 of 131994, Preclinical (animal, in vitro, computational): 8 of 131994, Reviews and meta-analyses: 1 of 131995, Human clinical research: 4 of 221995, Preclinical (animal, in vitro, computational): 16 of 221995, Reviews and meta-analyses: 1 of 221995, Other and not yet classified: 1 of 221996, Preclinical (animal, in vitro, computational): 8 of 101996, Other and not yet classified: 2 of 101997, Human clinical research: 1 of 81997, Preclinical (animal, in vitro, computational): 7 of 81998, Human clinical research: 3 of 141998, Preclinical (animal, in vitro, computational): 11 of 141999, Preclinical (animal, in vitro, computational): 8 of 82000, Human clinical research: 2 of 62000, Preclinical (animal, in vitro, computational): 4 of 62001, Preclinical (animal, in vitro, computational): 10 of 122001, Reviews and meta-analyses: 1 of 122001, Other and not yet classified: 1 of 122002, Preclinical (animal, in vitro, computational): 6 of 62003, Preclinical (animal, in vitro, computational): 14 of 142004, Human clinical research: 1 of 92004, Preclinical (animal, in vitro, computational): 7 of 92004, Reviews and meta-analyses: 1 of 92005, Preclinical (animal, in vitro, computational): 3 of 42005, Reviews and meta-analyses: 1 of 42006, Preclinical (animal, in vitro, computational): 8 of 102006, Reviews and meta-analyses: 1 of 102006, Other and not yet classified: 1 of 102007, Human clinical research: 1 of 62007, Preclinical (animal, in vitro, computational): 4 of 62007, Reviews and meta-analyses: 1 of 62008, Preclinical (animal, in vitro, computational): 4 of 52008, Reviews and meta-analyses: 1 of 52009, Human clinical research: 1 of 52009, Preclinical (animal, in vitro, computational): 2 of 52009, Reviews and meta-analyses: 2 of 52010, Preclinical (animal, in vitro, computational): 1 of 12011, Preclinical (animal, in vitro, computational): 4 of 52011, Reviews and meta-analyses: 1 of 52012, Human clinical research: 1 of 42012, Preclinical (animal, in vitro, computational): 3 of 42013, Preclinical (animal, in vitro, computational): 4 of 42014, Human clinical research: 2 of 92014, Preclinical (animal, in vitro, computational): 7 of 92015, Preclinical (animal, in vitro, computational): 1 of 12016, Human clinical research: 1 of 22016, Preclinical (animal, in vitro, computational): 1 of 22017, Preclinical (animal, in vitro, computational): 1 of 12018, Preclinical (animal, in vitro, computational): 1 of 12021, Preclinical (animal, in vitro, computational): 2 of 22024, Preclinical (animal, in vitro, computational): 2 of 2Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0204060197719861995200420132024
Counted PubMed publications by year of first publication. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197705016
197803014
197902002
198008008
1981360211
19820110112
19832151220
19846236641
19851133118
19861242128
19874171123
19881163121
19892211226
19901194226
19913210024
19926202028
19932123017
1994481013
19954161122
1996080210
199717008
19983110014
199908008
200024006
20010101112
200206006
20030140014
200417109
200503104
2006081110
200714106
200804105
200912205
201001001
201104105
201213004
201304004
201427009
201501001
201611002
201701001
201801001
202102002
202402002

Study types

Animal study351
Review37
In vitro study26
Observational human study22
Other clinical trial21
Not yet classified21
Computational study6
Randomized controlled trial6
Editorial, letter or other5
Case report4

Research areas

From MeSH major topics. A paper can be in several areas.

Neurological and mental health356
Cardiovascular53
Endocrinology44
Longevity and aging15
Musculoskeletal15
Cognitive health13
Oncology13
Immune system10
Gastrointestinal5
Metabolic health5
Dermatology3
Tissue repair3

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.

    European journal of anaesthesiology · February 1, 2009 · Randomized controlled trial · cited 14 times

    PMID 19142086 · DOI 10.1097/eja.0b013e32831c8644 · Human clinical research

  2. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency.

    The Journal of clinical endocrinology and metabolism · November 1, 2000 · Randomized controlled trial · cited 83 times

    PMID 11095454 · DOI 10.1210/jcem.85.11.6965 · Human clinical research

  3. Different effects of delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men.

    Hormone research · January 1, 1994 · Randomized controlled trial · cited 9 times

    PMID 7698722 · DOI 10.1159/000184207 · Human clinical research

  4. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.

    Neuropsychobiology · January 1, 1992 · Randomized controlled trial · cited 12 times

    PMID 1299794 · DOI 10.1159/000118919 · Human clinical research

  5. Reduction of immunoreactive ACTH in plasma following intravenous injection of delta sleep-inducing peptide in man.

    Psychoneuroendocrinology · January 1, 1989 · Randomized controlled trial · cited 17 times

    PMID 2554357 · DOI 10.1016/0306-4530(89)90004-8 · Human clinical research

  6. Synthetic delta-sleep-inducing peptide improves sleep in insomniacs.

    Lancet (London, England) · June 1, 1981 · Randomized controlled trial · cited 11 times

    PMID 6112579 · DOI 10.1016/s0140-6736(81)92417-x · Human clinical research

  7. [Using deltalicin for the treatment of patients with diabetic retinopathy].

    Eksperimental'naia i klinicheskaia farmakologiia · January 1, 2014 · Other clinical trial · cited 0 times

    PMID 25739189 · Human clinical research

  8. [Diabetes mellitus in elderly: geroprotective and antidiabetic properties of delta-sleep induced peptide].

    Advances in gerontology = Uspekhi gerontologii · January 1, 2004 · Other clinical trial · cited 2 times

    PMID 15754961 · Human clinical research

  9. Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial.

    Journal of clinical psychopharmacology · June 1, 1998 · Other clinical trial · cited 8 times

    PMID 9617990 · DOI 10.1097/00004714-199806000-00016 · Human clinical research

  10. Human plasma DSIP decreases at the initiation of sleep at different circadian times.

    Peptides · January 1, 1995 · Other clinical trial · cited 10 times

    PMID 8745061 · DOI 10.1016/0196-9781(95)02027-6 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Endogenous sleep-promoting substances and sleep regulation.

    Physiological reviews · April 1, 1989 · Review · cited 260 times

    PMID 2564687 · DOI 10.1152/physrev.1989.69.2.605 · Reviews and meta-analyses

  2. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · March 7, 2007 · Observational human study · cited 212 times

    PMID 17346943 · DOI 10.1016/j.euroneuro.2007.01.005 · Human clinical research

  3. Permeability of the blood-brain barrier to neuropeptides: the case for penetration.

    Psychoneuroendocrinology · January 1, 1985 · Review · cited 122 times

    PMID 3841397 · DOI 10.1016/0306-4530(85)90079-4 · Reviews and meta-analyses

  4. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.

    Proceedings of the National Academy of Sciences of the United States of America · March 1, 1977 · Animal study · cited 112 times · open access

    PMID 265572 · DOI 10.1073/pnas.74.3.1282 · Animal studies

  5. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia.

    Lancet (London, England) · November 1, 1983 · Animal study · cited 111 times

    PMID 6139573 · DOI 10.1016/s0140-6736(83)91273-4 · Animal studies

Latest publications

  1. Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models.

    Frontiers in pharmacology · October 8, 2024 · Animal study · cited 3 times · open access

    PMID 39444618 · DOI 10.3389/fphar.2024.1439536 · Animal studies

  2. Sensing the Bactericidal and Bacteriostatic Antimicrobial Mode of Action Using Raman Deuterium Stable Isotope Probing (DSIP) in Escherichia coli.

    ACS omega · May 22, 2024 · In vitro study · cited 12 times · open access

    PMID 38854576 · DOI 10.1021/acsomega.4c01666 · In vitro studies

  3. Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke.

    Molecules (Basel, Switzerland) · August 26, 2021 · Animal study · cited 2 times · open access

    PMID 34500605 · DOI 10.3390/molecules26175173 · Animal studies

  4. DSIP-Like KND Peptide Reduces Brain Infarction in C57Bl/6 and Reduces Myocardial Infarction in SD Rats When Administered during Reperfusion.

    Biomedicines · April 9, 2021 · Animal study · cited 4 times · open access

    PMID 33918965 · DOI 10.3390/biomedicines9040407 · Animal studies

  5. Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude.

    Life sciences · August 11, 2018 · Animal study · cited 13 times

    PMID 30107169 · DOI 10.1016/j.lfs.2018.08.026 · Animal studies

  6. Expression and Purification of Delta Sleep-Inducing Peptide Fused with Protein Transduction Domain and Human Serum Albumin in Pichia pastoris.

    Protein and peptide letters · January 1, 2017 · Animal study · cited 1 times

    PMID 28462721 · DOI 10.2174/0929866524666170426113022 · Animal studies

  7. Effect of Delta Sleep-Inducing Peptide on Functional State of Hepatocytes in Rats During Restraint Stress.

    Bulletin of experimental biology and medicine · February 23, 2016 · Animal study · cited 2 times

    PMID 26902351 · DOI 10.1007/s10517-016-3186-8 · Animal studies

  8. Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.

    Experimental biology and medicine (Maywood, N.J.) · February 10, 2016 · Observational human study · cited 11 times · open access

    PMID 26869608 · DOI 10.1177/1535370216632623 · Human clinical research

  9. [THE INFLUENCE OF DELTA SLEEP-INDUCING PEPTIDE ON FUNCTIONAL STATE OF RATS HEPATOCYTES IN FOOT-SHOCK STRESS].

    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · June 1, 2015 · Animal study · cited 0 times

    PMID 26470489 · Animal studies

  10. The influence of deltalycyn and transcranial cerebellar stimulation upon recovery of retina after photo stress in patients with diabetic retinopathy.

    Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi · October 1, 2014 · Observational human study · cited 1 times · open access

    PMID 25581971 · Human clinical research

Browse all 499 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Delta Sleep-Inducing Peptide; DSIP; Emideltide; Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

((TITLE_ABS:"Delta Sleep-Inducing Peptide" OR CHEM:"Delta Sleep-Inducing Peptide") OR (TITLE_ABS:"DSIP" OR CHEM:"DSIP") OR (TITLE_ABS:"Emideltide" OR CHEM:"Emideltide") OR (TITLE_ABS:"Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu" OR CHEM:"Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Delta Sleep-Inducing Peptide (DSIP) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/dsip